QUICKLINKS AND VIEW OPITONS
Hydroxychloroquine + azithromycin, 66% lower risk of death, University of Milan Covid-19 study
Friday, July 31, 2020 6:11 pm Email this article
“… the use of hydroxychloroquine + azithromycin was associated with a 66% reduction in risk of death [in Covid-19 patients] as compared to controls…” according to a study from researchers at the University of Milan, Italy published on July 29, 2020.
“Our results are remarkably similar to those shown by Arshad et al.  [The Henry Ford Health System study done in Detroit, Michigan].” (A summary of that study is posted here.
The study is posted here:
Antonella d’Arminio Monforte, et al. Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation? International Journal of Infectious Diseases, 2020 July 29.
Author’s Contact Info
Antonella d’Arminio Monforte
Institute of Infectious and Tropical Diseases Department of Health Sciences
ASST Santi Paolo e Carlo
University of Milan, Italy
Via A. di Rudinì, 8 20142 Milan Italy
Tel: +39 0281843045
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.